Author: Biz India

No effective treatment exists for estimated 250,000 children born worldwide each year (20,000 in the US) with pediatric minimally verbal autism           By Dakota Orlando                                                                                               New York, June 07, 2019 – Q BioMed, a commercial-stage biotechnology acceleration firm today announced advancements on several fronts for its key asset, QBM-001, in the treatment of pediatric minimally verbal autism (PMVA), a rare autism spectrum disorder for which no effective treatment currently exists. Globally, over 250,000 children are born with PMVA per year, 20,000 of them the United States. “Children affected by pediatric minimally verbal autism are in dire need of an effective...

By Rachel Goemaat TRENTON, N.J., June 6, 2019 – The New Jersey Economic Development Authority (NJEDA) announced today that it has closed on a $250,000 convertible note to River Edge-based InquisitHealth to help the health technology company further its mission of helping patients with diabetes, asthma, hypertension, and other chronic diseases overcome the social determinants of health and adopt healthy lifestyle changes through its peer mentoring program. The funding was provided through the NJEDA’s NJ CoVest Fund, which is designed to help emerging technology companies bridge the funding gap between product development and commercialization and further the NJEDA’s ability to support businesses throughout their growth lifecycle....